Latest news
Loading news…
Alesta Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Leiden, Zuid-Holland, The Netherlands Founded 2021 1-10 employees For Profit
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $147K
Company Info
- Founded
- 2021
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 18
- HQ
- Leiden, Zuid-Holland, The Netherlands
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.6
- Trend (30d)
- 0.6
- Trend (90d)
- -0.3
Key People at Alesta Therapeutics
Chief Executive Officer
1
professional contacts at Alesta Therapeutics
Contact execs at Alesta Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Alesta Therapeutics
Loading news…
FAQs about Alesta Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.